First Eagle Investment Management
PROF

First Eagle Investment Management’s Profound Medical PROF Stock Holding History

First Eagle Investment Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09M Buy
322,707
+10,000
+3% +$69.1K ﹤0.01% 319
2025
Q4 		$2.46M Buy
312,707
+21,316
+7% +$137K ﹤0.01% 310
2025
Q3 		$1.45M Buy
291,391
+169,352
+139% +$865K ﹤0.01% 322
2025
Q2 		$720K Buy
+122,039
New +$645K ﹤0.01% 358

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

First Eagle Investment Management's PROF Position: Q1 2026 in Review

First Eagle Investment Management increased its Profound Medical (PROF) stake by 3.2% in Q1 2026, buying an estimated $69.1K and bringing the position to 322,707 shares worth $2.09M. The position accounts for ﹤0.01% of the portfolio, ranked #319.

First Eagle Investment Management first reported a position in PROF in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.46M in Q4 2025. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • First Eagle Investment Management held 322,707 shares of Profound Medical worth $2.09M as of Q1 2026.
  • First Eagle Investment Management bought 10,000 Profound Medical shares in Q1 2026, an estimated $69.1K.
  • Profound Medical made up ﹤0.01% of First Eagle Investment Management's portfolio in Q1 2026, its #319 holding.
  • First Eagle Investment Management first reported a position in Profound Medical in Q2 2025 and has held it in 4 quarters since.
  • First Eagle Investment Management's Profound Medical position peaked at $2.46M in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on First Eagle Investment Management's 13F filing for Q1 2026, filed 12 May 2026.